The inducible nitric oxide synthaseinhibitor 1400W as a potential treatment for retinal diseases

作     者：Sven Schnichels Stephanie C.Joachim Sven Schnichels;Stephanie C.Joachim

作者机构：University Eye Hospital TübingenCentre for OphthalmologyTübingenGermany Experimental Eye Research InstituteUniversity Eye HospitalRuhr-University BochumBochumGermany 

出 版 物：《Neural Regeneration Research》 (中国神经再生研究（英文版）)

年 卷 期：2021年第16卷第6期

页      面：1221-1222页

核心收录：

学科分类：1002[医学-临床医学] 100212[医学-眼科学] 10[医学] 

基　　金：supported in part by the set Stiftung 

主　　题：AMD diseases potential 

摘      要：The overproduction of reactive oxygen species is defined as oxidative *** deprived oxygen supply in tissues is known as *** mechanisms contribute to the pathogenesis of several retinal diseases,like glaucoma,age-related macular degeneration(AMD),and retinal *** is a neurodegenerative disease defined by a progressive loss of retinal ganglion cells(RGCs)and their axons causing visual field defects,which ultimately leads to *** AMD pathogenesis is further characterized by soft drusen,it involves the retinal pigment epithelium and the Bruch’s membrane-choroid complex.